Cortical neurons rapidly die in necrosis due to poor glucose uptake in the low-density (LD) culture under serum-free condition without any supplements. The scanning and transmission electron microscopical analyses characterized the necrosis by membrane disruption, mitochondrial swelling and loss of cytoplasmic electron density. High-glucose treatment delayed the neuronal death by suppressing necrosis, but induced apoptosis through increase in Bax levels, cytochrome c release, caspase-3 activation and DNA ladder formation. Although pyruvate as well as high glucose inhibited necrotic cell death and rapid decrease in cellular ATP levels, possibly related to decreased [ 3 H]-2-deoxy glucose uptake under the serum-free condition, it did not induce apoptosis. Protein kinase C inhibitors blocked these changes related to the cell death mode switch. Several neurotrophic factors did not affect the necrosis, but potentiated high-glucose-induced survival activity, while inhibiting cytochrome c release. All these results suggest that high-glucose treatment causes neuronal cell death mode switch by inhibiting necrosis, while inducing apoptosis, which is prevented by neurotrophic factors.
Introduction
Traumatic brain injury causes cell death through direct mechanical damage, as well as through delayed injury induced by endogenous, autodestructive processes. 1 Such death may occur through either necrosis or apoptosis. 2, 3 Ischemia and/or metabolic impairment accompany traumatic central nervous system injury in animals 4, 5 and in humans. 6, 7 The ischemic area induced by middle cerebral artery occlusion (MCAO) can be divided into an ischemic core and the penumbra area. In the core, there is a rapid necrotic cell death, whereas in the penumbra apoptosis occurs more slowly. [8] [9] [10] Since necrotic cells induce secondary damages due to the damage of surrounding cells, while apoptotic cells do not, 11, 12 a switch in the mode of cell death from necrosis to apoptosis could play a role in ameliorating the spread of a cell death in the brain.
Necrosis is characterized by loss of membrane integrity, disruption of intracellular organelles, cellular swelling and lysis, while apoptosis involves reduction of intracellular volume, nuclear condensation and fragmentation. 13, 14 Although the molecular mechanisms underlying apoptosis execution are now well characterized, 15 little is known about the mechanisms underlying necrosis. In previous studies, we observed that cortical neurons die by necrosis in low-density and serum-free culture, and the mode of cell death changes to apoptosis as cell density increases. 16, 17 Most recently, we found that some neuronal conditioned medium factors switch the cell death mode from necrosis to apoptosis. 17 This switch in the mode of cell death is correlated with cellular ATP levels, as it is altered by various reagents such as oligomycin (mitochondrial F o -F 1 ATPase inhibitor), caspase inhibitor or poly (ADP-ribose) polymerase (PARP) inhibitor. These findings are closely related to observations that oligomycin switches the apoptosis induced by Fas or oxidative stress to necrosis. 18, 19 Since high energy levels are required for the execution of apoptosis but not for necrosis, 20, 21 ATP may have a key role in regulating the mode of cell death. 22, 23 However, it remains to be seen whether the increase in cellular ATP levels might switch the necrotic cell death to apoptotic one.
Alteration of glucose disposition might also be related to the cell death mode switch, since the level of glucose uptake is low in the necrotic ischemic core, while it is high in the surrounding penumbra area. 9 In the present study, we attempted to see whether such cell death mode switch is affected by raising cellular ATP levels by adding high glucose.
Results
Increase in cellular ATP levels and survival activity by high-glucose treatment When cortical cells of embryonic (E17) rats were seeded at 1 Â 10 5 cells/cm 2 (low-density; LD) and cultured with or without serum, most of the cells attached to the plate within 1 h. The population of microtubule-associated protein-2 (MAP-2, a neuron marker)-positive cells was 95%, while those of glial fibrillary acidic protein (GFAP, an astrocyte marker) and OX-42 (a microglia marker)-positive cells were 3.4 and 0.8%, respectively (data not shown), indicating that the cells were mostly neurons. In the presence of serum, most neurons looked healthy and had neurites by 12 h (Figure 1Aa ). In contrast, serum-free neurons exhibited dilated cell volume, and had no neurites ( Figure  1Ab ). Our previous study revealed that the neurons in this serum-free culture are clearly characterized to die by necrosis. 17 In Â 5 glucose (87.5 mM) and serum-free medium, on the other hand, most neurons appeared healthy and had neurites (Figure 1Ac) .
The cellular ATP level of cortical neurons was rapidly decreased in the LD and serum-free culture, while there was no decrease in the ATP level in the presence of serum ( Figure 1B ). When cortical neurons were grown in the presence of various concentrations (1 Â , 3 Â and 5 Â ; 17.5, 52.5 and 87.5 mM) of glucose, a concentration-dependent increase in cellular ATP levels was observed by 6 h ( Figure 1B) . Survival activity measured with WST-8 reduction activity due to mitochondrial activity was also rapidly decreased in the LD and serum-free culture, while no change was seen in the presence of serum ( Figure 1C ). The addition of high-glucose concentration-dependently increased the survival activity. Similar neuroprotection by high-glucose treatments was also observed in the decrease in LDH release due to loss of membrane integrity ( Figure 1D ). However, addition of 70 mM mannose to normal-glucose culture did not affect the survival activity in the WST-8 reduction assay ( Figure 1E ), suggesting that the neuroprotection by high-glucose treatment is unlikely due to the high osmolarity. Thus, this mechanism through a delay of decrease in ATP levels may be involved in the necrosis inhibition.
Scanning electron microscopy analysis of cortical neuron cultured under the serum-free and high-glucose condition Scanning electron microscopy (SEM) indicated that the cortical neuron in the presence of serum showed lamellipodium at the time point of 6 h after the start of culture ( Figure  2Aa ). On the other hand, neuron in the serum-free culture showed marked membrane disruption on the lamellipodium at 6 h; then the total cell structure except for nuclei was disintegrated at 12 h (Figure 2Bb ). Addition of high glucose completely protected the neuron from membrane disruption, but induced membrane smoothing, bubbling and cell fragmentation (Figure 2Ca,b) .
TEM analysis of high-glucose-induced cell death mode switch in the serum-free culture On the other hand, transmission electron microscopy (TEM) indicated that cellular organelles appeared healthy in the neurons grown with serum. Neither damages in membrane and nucleus (Figure 3Aa ) nor mitochondrial swelling ( Figure  3Ab ) was observed. However, neurons grown without serum had disrupted plasma membranes without damage in nucleus ( Figure 3Ba ) and swollen mitochondria (Figure 3Bb ). The Â 5 glucose treatment alleviated these membranes and mitochondrial damages occurred in serum-free culture, but caused nuclear fragmentation (Figure 3Ca,b) .
Characterization of cell death mode switch induced by high-glucose treatment
Fluorescein isothiocyanate (FITC)-conjugated annexin V has been utilized to detect the externalization of phosphatidylserine that occurs at an early stage of apoptosis. 24 Propidium iodide (PI) is used for a necrosis marker due to the cell membrane destruction. Very few annexin V-positive cells (12.9% of total cells) were observed 3 h after the start of the LD culture containing normal, Â 1 glucose (17.5 mM), in which PIpositive cells were predominant (68.6%, see Figure 4Aa The conversion of procaspase-3 to active caspase-3 is generally accepted to be the most reliable indicator of apoptosis. 25 As shown in Figures 4Ca and D, most cells were PI-positive and active caspase-3-negative in Â 1 glucose 12 h after the start of culture. The apoptosis/necrosis ratio (active caspase-3-positive cells/PI-positive cells) was calculated to be 0.06 in normal-glucose culture. Similar high-glucoseinduced cell death mode switch to apoptosis was also observed in this paradigm of experiments (Figures 4Cb,c) . The apoptosis ratio was markedly increased to 2.50 and 5.45 by Â 3 and Â 5 glucose (Figure 4D ), respectively. When cell lysates were used for the measurement of caspase-3-like activity, high-glucose treatments significantly increased the activity in a concentration-dependent manner ( Figure 4G ).
Caspase-3 activation is followed by DNA fragmentation, which is manifested by TUNEL activity and DNA ladder formation. As shown in Figure 4Ea and F, TUNEL activity was not observed under the normal-glucose condition, while it was marked by the addition of high glucose (Figure 4Eb ,c, F) at 24 h after the start of culture. Figure 4H showed typical DNA ladder formation only in the high-glucose culture. High-glucose-caused induction of cellular proapoptotic mechanisms
To characterize the apoptosis mechanisms by high-glucose treatment, Western blot analyses for Bcl-2 family proteins and caspase molecules were carried out. As shown in Figure 5A , proapoptotic Bax expression was increased linearly till 12 h after the start of high-glucose culture. At the time point of 12 h, a slight increase in the level of Bim, another proapoptotic protein was observed, while there was no or slight decrease in Bcl-2 or Bcl-xL, respectively ( Figure 5B ). Cytochrome c is a key molecule in the activation of caspase-9 and caspase-3, and its release from mitochondria is regulated by the actions of Bcl-2 family proteins, such as proapoptotic Bax and antiapoptotic Bcl-2. [26] [27] [28] As shown in Figure 5Ca -c, neurons were double-labeled with cytochrome c and Mitotracker Red CMXRos, a fluorescent probe for mitochondria at 12 h in normal-glucose and serum-free medium. In the high-glucose culture, however, this double labeling disappeared by 12 h (Figure 5Cd-f) . These findings suggest that the serum-free stress itself did not cause cytochrome c release from mitochondria or proapoptotic mechanism, while the high-glucose treatment did.
Bax-mitochondrial pathway drives both caspase-9 and caspase-3 activation through mitochondrial cytochrome c release, 29 while Fas/TNF receptor and endoplasmic reticulum (ER)-stress pathways drive caspase-8 and caspase-12, respectively. 30, 31 The high-glucose treatment markedly increased active caspase-9 and caspase-3 levels ( Figure 5D ). However, the treatment did not affect the caspase-12 levels, while significant caspase-8 levels were not detected from both normal and high-glucose preparations at 12 h (data not shown). Pyruvate prevents the necrosis through raising cellular ATP levels, but does not induce apoptosis
Recovery of reduced [
The addition of 10 mM pyruvate to the serum-free culture markedly delayed the decline of WST-8 survival activity (Figure 7a ). Approximately 80% of survival activity retained at the time point of 24 h after the serum-free culture, and its activity was more potent than the high-glucose ( Â 5)-mediated one (58.3%). Concentration dependency also supports the view that pyruvate has higher potency in retaining the survival activity than glucose ( Figure 7b ). As shown in Figure 7c , the rate of decrease in ATP levels was slower with pyruvate than that with high glucose. Approximately 50% of initial ATP levels were retained in neurons treated with pyruvate at 12 h after the start of serum-free culture, while less than 10% levels were with high glucose. However, the pyruvate treatment completely prevented necrosis manifested with PI staining, but did not induce apoptosis with annexin V staining (Figure 7d ).
High-glucose-induced survival activity through phospholipase C and protein kinase C activation
We attempted to examine the effects of inhibitors for various protein kinases on the neuronal survival activity in the highglucose culture, to get some clues for the cellular signaling of high-glucose-induced cell death mode switch. Here we used various representative inhibitors such as herbimycin A (3 mM) for tyrosine kinase, calphostin C (3 mM) and GF109203X (0.1 mM) for protein kinase C (PKC), wortmannin (1 mM) for phosphatidylinositol-3 kinase (PI-3 kinase), U0126 (1 mM) for mitogen-activated protein kinase kinase (MEK), SP600125 (1 mM) for c-Jun N-terminal kinase (JNK), SB203580 (1 mM) for p38 mitogen-activated protein kinase (p38MAPK), KT5720 (1 mM) for cyclic AMP-dependent protein kinase (PKA) and KN93 (1 mM) for Ca 2 þ /calmodulin kinase II. These compounds alone did not affect survival activity under the normalglucose and serum-free culture (data not shown). Among nine compounds, only PKC inhibitors (calphostin C and GF109203X) significantly attenuated it ( Figure 8A ). Thapsigargin (1 mM), an intracellular Ca 2 þ store depletor, and U73122 (1 mM), a phospholipase C inhibitor, but not U73343 (1 mM), its inactive isomer, blocked the high-glucose-induced survival activity. Furthermore, high-glucose treatment significantly increased the PKC activity in a calphostin C-and U73122-reversible manner ( Figure 8B ). All these findings suggest that the high-glucose-induced survival activity is mediated through phospholipase C and PKC mechanisms.
Protein kinase C-mediated cell death mode switch induced by high glucose
In the experiment using double staining with Hoechst 33342 and PI staining, neurons in the normal-glucose and serum-free culture were intensely stained by PI, but not by Hoechst 33342 (Figure 8Ca,b) . In the high-glucose culture, however, most of the neurons showed marked nuclear condensation or fragmentation stained by Hoechst 33342, but no PI-positive neuron was observed (Figure 8Cc,d ). Such typical cell death mode switch was clearly reversed by calphostin C (Figure 8Ce ,f) and GF109203X (data not shown). Calphostin C reversal of high-glucose-induced cell death mode switch was also observed when colabeling with annexin V and PI was carried out (Figure 8Cg-i) . Furthermore, the proapoptotic cytochrome c release and enhanced Bax expression induced by high glucose were also blocked by calphostin C (Figure 8D , E).
Potentiation of high-glucose-induced survival activity and blockade of high-glucose-induced cytochrome c release by neurotrophic factors
The addition of nerve growth factor (NGF, 100 ng/ml), brainderived neurotrophic factor (BDNF, 100 ng/ml) or basic fibroblast growth factor (bFGF, 100 ng/ml) did not affect the survival activity 12 h after the start of serum-free culture, measured with WST-8 assay ( Figure 9A ). However, these neurotrophic factors all significantly potentiated the highglucose-induced survival activity. Further addition of herbimycin A (3 mM) or K252a (1 mM, a TrkB inhibitor) blocked the BDNF-induced potentiation, while inhibitors alone did not affect the basal survival activity (data not shown).
On the other hand, BDNF treatment inhibited the highglucose-induced cytochrome c release from mitochondria (Figure 9Ba-c) , in a herbimycin A-or K252a-reversible manner (Figure 9Bd-i) . However, the inhibitors alone did not affect the high-glucose-induced cytochrome c release (Figure9j-o). All these findings suggest that high-glucose treatment converted the serum-free stress-induced necrosis to apoptosis, which will be blocked by some tyrosine kinases activated by neurotrophic factors.
Discussion
Neuronal death observed under serum-free conditions without any supplements has unique features, such as resistance to the neurotrophic factors, NGF, BDNF or bFGF ( Figure 9A ). In the present study, such cell death was found to be necrotic, without any apoptotic features (Figures 2-4) . Compared to cells cultured in the presence of serum, [ 3 H]-2-DG uptake into cells cultured in the absence of serum was markedly reduced (Figure 6a ). This might be related to the rapid decrease in cellular ATP levels ( Figure 1B) , and to the induction of necrosis in serum-free culture (Figures 2-4) . Our initial intention was to protect against necrotic death, following an addition of excess amount of glucose by raising cellular ATP Glucose-induced necrosis-apoptosis switch R Fujita and H Ueda levels. As expected, elevated glucose uptake inhibited necrosis in serum-free cultured neurons (Figure 2-4, 8C) , which was correlated to slowing down of the decrease in cellular ATP levels ( Figures 1B) .
The cell death mode switch from necrosis to apoptosis by high-glucose treatment was clearly evidenced by SEM, TEM and immunocytochemical experiments using several specific molecular markers (Figures 2-4) . Although the molecular mechanisms of necrosis induction and its inhibition by highglucose treatment in the serum-free culture remain to be determined, the decrease in cellular ATP levels is supposed to be involved in the necrosis-related osmotic imbalance, possibly through decreased Na þ -K þ ATPase activity and aquaporin membrane translocation. [32] [33] [34] [35] In the serum-free culture, there was a rapid decrease in [ 3 H]-2-DG uptake activity, possibly due to loss of membrane translocation of GLUT 1 and GLUT4 (Figure 6b ). High-glucose treatments showed moderate recovery of [ 3 H]-2-DG uptake without changes in the membrane translocation of GLUT molecules (Figure 6a,b) . Thus, the slowing of the decrease in cellular ATP levels and prevention of necrosis by high-glucose treatment are likely due to the moderate glucose incorporation through mechanisms distinct from GLUT1 or GLUT4. More direct evidence for the involvement of ATP rescue in the necrosis prevention was observed when pyruvate was added to the serum-free culture. Pyruvate showed more potent activity in raising survival activity and cellular ATP levels than high glucose (Figure 7a-c) . Big difference between the effects of glucose and pyruvate would be seen in the fact that glucose treatment induced apoptosis as well as necrosis inhibition, while pyruvate did not induce apoptosis. Thus, it is suggested that high glucose has additional mechanisms to induce apoptosis.
Some molecular machineries related to high-glucoseinduced apoptosis were identified. Among several pathways to caspase-3 activation, the cytochrome c release regulated by Bcl-2 family proteins would be the major pathway. Although the serum-free stress itself had no effect on the proapoptotic cytochrome c release, high-glucose treatments caused the release ( Figure 5C ). High-glucose treatments increased the protein expression of Bax and Bim, both of which stimulate the release of cytochrome c, 36, 37 while decreased the expression of Bcl-xL, which inhibits the release (Figures 5A, B) . 38, 39 As high-glucose stimulation caused a marked activation of caspase-9 and caspase-3, the high-glucose-induced alteration of the expression of proapoptotic Bcl-2 family proteins may underlie cytochrome c release and its downstream sequel to induce apoptosis.
From the study using enzyme inhibitors, it was found that the high-glucose-induced survival mechanisms are mediated through phospholipase C and PKC mechanisms. The PKC mechanisms were supposed to be also involved in the highglucose-induced cell death mode switch, as measured with Hoechst 33342-, PI-, annexin V-staining as well as (Figure 6a ) unlikely causes these apoptotic mechanisms, another mechanism should be considered. Most recently, it was reported that the G-protein-coupled receptor Gpr1p is involved in the high-glucose (50 mM)-induced [Ca 2 þ ] i -increase, through an activation of phospholipase C in budding yeast. [40] [41] [42] Although any mammalian homologs are not found by database search at present, it might be a fascinating subject to relate the high-glucoseinduced cell death mode switch through PKC mechanisms to unidentified low-affinity glucose receptor.
In our previous study, the conditioned medium (CM) factors from high-density and serum-free culture also caused similar cell death mode switch through PKC mechanisms. 17 Although CM factors do not appear to contain high amounts of glucose, the possibility that high glucose stimulates putative receptors for CM factors could not be excluded. However, the highglucose-induced PKC activation (B30%) was three times more potent than the CM factors (B10%), though the potencies in survival or apoptosis induction were equivalent between both factors. 17 Thus, their receptor mechanisms stimulating PKC are likely different.
It is interesting to discuss the in vivo role of the present highglucose-induced cell death mode switch. The first issue is on the relationship between the concentration used for in vitro high-glucose treatment and in vivo glucose level in the ischemic brain. As seen in Figures 1, 4 and 6 , several changes related to this mode switch also occur when Â 3 glucose is used in vitro. On the other hand, there are reports that the local infarction of brain capillary vessels increased over two-fold blood and glucose supply in the penumbra. 9, 43 As it is reasonably expected that the higher increase in in vivo glucose level might occur in the specific area and/or during specific period after the ischemia, the high-glucose-induced neuronal death mode switch might have some roles in vivo.
The second issue is how the glucose application in vivo affects the ischemic neuronal damages. We observed that the topical vitreous application of glucose markedly prevented the neuronal necrosis in the retinal ischemia/reperfusion model, in which study coinjection of herbimycin A blocked the glucoseinduced neuroprotection, and caused apoptosis characterized by nuclear fragmentation in TEM analysis. These findings suggest that some neurotrophic factors secreted from unidentified cells may inhibit the glucose-induced apoptosis in vivo. 44 This hypothesis may be in part confirmed by the present in vitro study. As shown in Figure 9 , high-glucoseinduced survival activity was potentiated, while cytochrome c release was blocked by BDNF and some other neurotropic factors, and these actions were completely abolished by tyrosine kinases. All these findings suggest that high-glucose treatments cause a cell death mode switch from necrosis to apoptosis, which in turn is liable to protection by serum factors or neurotrophic factors.
In conclusion, we demonstrated that the high-glucose treatments inhibit necrosis, possibly through slowing down the rapid decrease in cellular ATP levels, and at the same time induce apoptosis through phospholipase C and PKC mechanisms. The cell death mode switch mechanisms induced by high-glucose treatments may provide a new strategy of use of neurotrophic factors to cure necrosis in vivo.
Materials and Methods

Materials
Cell culture medium, fetal bovine serum (FBS) and herbimycin A were purchased from Gibco BRL (Tokyo, Japan). [ 32 P]-ATP (3000 Ci/mmol) was bought from Amersham Pharmacia Biotech (Tokyo, Japan). [ 3 H]-deoxy-glucose (10 Ci/mmol) was from Daiichi Pure Chemicals (Tokyo Japan). D-( þ )-glucose, D-( þ )-mannose and SB203580 were bought from Nacalai Tesque (Kyoto Japan). Antibody against glucose transporter 1 (GULT1) and glucose transporter 4 (GLUT 4) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Pyruvate, U0126, KN93, K252a and thapsigargin were purchased from Sigma (Tokyo, Japan). Calphostin C and wortmannin were purchased from Wako Pure Chemicals (Tokyo, Japan). KT5720, U73122 and U73343 were purchased Figure 9 Potentiation of high-glucose-induced survival activity and blockade of high-cytochrome c release by neurotrophic factors. (A) Potentiation of highglucose ( Â 5 glc)-induced survival activity by several neurotrophic factors (100 ng/ml) in WST-8 reduction activity. Herbimycin A (3 mM) and K252a (1 mM, a TrkB receptor inhibitor) were added with high glucose and BDNF in beginning of serum-free culture in cortical neurons, 12 h after start of culture. The neurotrophic factors, NGF, BDNF and bFGF, were used at 100 ng/ml. (B) CMXRos (red; DC m ) and cytochrome c (FITC labeling: green; cyto c) staining were observed in cortical neurons treated with serum-free 5 Â glucose þ BDNF (a-c), serum-free from Funakoshi (Tokyo, Japan). GF109203X was purchased from Calbiochem (San Diego, CA, USA). Herbimycin A was purchased from LKT laboratories (St. Paul, MN, USA). Neuronal growth factor (NGF) was purchased from Alomone Labs. (Jerusalem, Israel). bFGF was purchased from Austral Biologicals (San Ramon, CA, USA). BDNF was a gift from Sumitomo Pharmaceutical (Osaka, Japan). SP600125 was a gift from T Iwamura (Gifu Pharmaceutical University).
Primary culture
Primary cultures of 17-day embryonic rat cerebral cortex cells were produced according to the previously reported protocol. 17, 45 Different groups of cultures were supplemented with 0, 17.5, 35.0, 52.5 and 70 mM glucose (final glucose concentration, 17.5, 35.0, 52.5, 70.0 and 87.5 mM). They were seeded onto 96-well culture plates, eight-well Lab-Tek TM chambers, or 3.5 and 9.0 cm culture dishes, which had been all coated with poly-DL-ornithine, and cultured at 371C in 5%-CO 2 atmosphere.
Measurement of intracellular ATP levels
Intracellular ATP levels were measured by the luciferin-luciferase method, using ATP-Determination Kit (Molecular Probes, Eugene, OR, USA). 46 The entire cells of culture including any floating cells (2 Â 10 6 cells) were subjected to the assay. The cells were twice washed with ice-cold phosphate-buffered saline (PBS) and suspended in cell dilution buffer (4 mM EDTA, 100 mM Tris-HCl pH7.75). Aliquots (20 ml) of cell lysates were added with the Reaction Solution (200 ml) containing 0.5 mM luciferin, 1.25 mg/ml luciferase and 1 mM DL-dithiothreitol (DTT) from the Kit, and used for bioluminescence assay, using LUMAT LB 9507 from EG&G Berthold (Bad Wildbad, Germany).
WST-8 assay
To assess the viability of cells, we performed 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-8) reduction assay kit (Dojin Lab., Tokyo, Japan), according to the manufacturer's instructions. WST-8 was added to the culture for 3 h at 371C prior to the colorimetry. Percentage of WST-8 activity was represented as the ratio of activity at different time points to that in the beginning of culture.
LDH release assay
Cell damage was quantified by measuring activities of the cytosolic lactate dehydrogenase (LDH) released into the culture medium from damaged cells, by using the Cytotoxicity Detection Kit from Roche Molecular Biochemicals (Mannheim, Germany) according to the manufacturer's instructions. Briefly, cells (3.2 Â 10 3 cells/100 ml/well) were seeded on a 96-well culture dish. For maximum LDH release, 100 ml of 2% Triton X-100 was added to the culture (100 ml), and incubated for 30 min at 251C. Aliquots (100 ml) of lysates were transferred to a 96-well dish, and then the reaction mixture (100 ml) from the Kit was added to the wells and incubated for 90 min at 251C in the dark. Enzyme activity was evaluated by colorimetry. For the LDH release into the culture medium from cells at corresponding periods, aliquots (50 ml) of culture medium were transferred to a 96-well dish and added with 50 ml of 2% Triton X-100, followed by the procedures, as mentioned above. Results were represented as the percentage of the maximum LDH release.
Scanning electron microscopy
Cultured cortical neuron was seeded in the cover glass for SEM. Neurons were rinsed briefly in PBS (pH 7.4), and fixed in 2.5% glutaraldehyde in 0.1 M PBS (pH 7.4) overnight at 41C. Neurons were then rinsed in buffer, and postfixed with 2% osmium tetroxide for 1 h at 251C. Dehydration was carried out through an ascending series of alcohols, transferred to isoamyl acetate and a critical-point -drier was used. Finally, these samples were sputter coated with gold/palladium. The stained samples were observed under an electron microscope (JSM-35C; JEOL, Tokyo, Japan).
Transmission electron microscopy
Cultured cortical neurons were fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 1 h at 251C. The fixed cortical neurons were postfixed with 2% osmium tetroxide for 1 h at 251C, dehydrated in graded alcohol series, and embedded in Epon812. Ultrathin sections (80 nm thick) were cut with an Ultracut S (Leica, Austria), and then stained with uranyl acetate and lead citrate for 30 and 5 min, respectively. The stained sections were observed under an electron microscope (JEM-1210; JEOL, Tokyo, Japan).
Annexin V-binding and PI-staining assay
To assess the simultaneous observation of early phase of apoptotic and necrotic features, cortical cells on an eight-well Lab-Tek TM chamber were treated with annexin V-fluorescein (annexin V-FLUOS Staining Kit from Roche Molecular Biochemicals) and 10 mg/ml PI for 15 min at 251C in the dark. Cells were washed once with ice-cold PBS, fixed with 4% paraformaldehyde (PFA) in PBS for 30 min at 251C, and observed under a fluorescence microscope (LSM 410; Carl Zeiss; Tokyo, Japan).
Immunocytochemistry of caspase-3
Cortical cells on an eight-well Lab-Tek TM chamber were fixed with 4% PFA in PBS for 30 min, followed by permeabilization using 0.1% Triton X-100 in PBS. They were incubated in blocking buffer (2% low-fat milk powder, 2% bovine serum albumin, 0.1% Tween-20, in PBS, pH 7.4) for 1 h at 251C. Anticleaved caspase-3 antibody (1 : 50; Cell Signaling, Tokyo, Japan) was added to the cells. After 2 h incubation at 251C and washing, the cells were incubated with FITC-conjugated anti-rabbit immunoglobulin (IgG) (1 : 200; Cappel, Aurora) for 4 h at 251C. Immunolabeled cells were observed under a fluorescence microscope.
TUNEL analysis
DNA fragmentation in apoptotic cells was visualized by terminal deoxyribonucleotidyl transferase-mediated dUTP-biotin nick endlabeling (TUNEL, Invitrogen, Tokyo, Japan). 47 Cells on an eight-well Lab-Tek TM chamber, preincubated with 10 mg/ml PI at 371C for 30 min, were washed twice in ice-cold PBS, fixed with 4% PFA in PBS for 30 min, and permeabilized with 50 and 100% methanol for 5 min each. The treated cells were reacted with the TUNEL solution from Roche Molecular Biochemicals for 1 h at 371C. They were washed twice in PBS, and added by blocking buffer (1% bovine serum albumin in PBS, pH 7.4) for 1 h at 251C, followed by incubation with streptavidin-FITC (1 : 100; Vector Laboratories, Burlingame, CA, USA) for 1.5 h at 251C, for observation with fluorescence microscope.
Measurement of activity of caspase-3-like proteases
Culture cells were lysed with lysis buffer (0.5% Triton X-100, 20 mM EDTA and 50 mM Tris-HCl, pH 8.1). The cell lysate was centrifuged at 15 000 rpm for 10 min, and the supernatant was used for the enzymatic assay. The diluted cell lysate (12 ml; 1-3 mg/ml) was added to 380 ml of reaction buffer (0.1% Triton X-100, 20% glycerol, 0.5 mM EDTA, 1 mM fluorogenic peptide substrate, acetyl-Asp-GluVal-Asp-a-(4-methyl-coumaryl-7-amide) (Ac-DEVD-MCA) for caspase-3-like protease activity, and was incubated for 1 h at 301C. 
Analysis of DNA fragmentation
Cells (1 Â 10 5 cells/cm 2 ) on 9-cm dishes were harvested and centrifuged at 350 Â g for 5 min, and the pellet was used for DNA fragmentation analysis, as previously described. 48 Briefly, the cells were lysed in 250 ml of lysis buffer (5 mM Tris-HCl, 20 mM EDTA and 0.5% Triton X-100, pH 8.1) with gentle shaking for 15 min at 41C. The lysates were centrifuged at 6000 Â g for 10 min at 41C to separate the fragmented DNA (supernatant) and intact chromatin DNA (pellet). The fragmented DNA was extracted with phenol/chloroform/isoamylalcohol, and the DNA in the aqueous phase was precipitated with 2 volumes of ethanol following the addition of sodium acetate (final concentration, 0.3 M). The DNA was then collected by centrifugation (14 000 Â g for 10 min at 41C) and dried. The samples were finally dissolved in TE buffer (10 mM Tris-HCl and 1 mM EDTA, pH 8.1), incubated for 1 h at 371C with RNase A (10 mg/ml), and electrophoresed on a 2% agarose gel. The gel was stained with ethidium bromide, and then photographed on an ultraviolet illuminator.
Western blot analysis
SDS-polyacrylamide gel electrophoresis by using 12% polyacrylamide gel and immunoblot analysis was performed as described. 49 Anti-Bcl-2, antiBax, anti-Bim, anti-Bcl-xL (1 : 1000; Santa Cruz Biotechnology, CA), anticleaved caspase-3 (1 : 1000; Cell Signaling, Tokyo, Japan), anticaspase-8, anticaspase-9 (1 : 1000; Stressgen, Victoria, Canada) and anticaspase-12 (1 : 1000; Oncogene, CA, USA) were used as primary antibodies. Visualization of immunoreactive bands was performed by using an enhanced chemiluminescent substrate (Super Signaling Substrate; Pierce Chemical Co., Rockford, IL, USA) for the detection of horseradish peroxidase.
Mitotracker red CMXRos and cytochrome c double labeling
Cortical cells on an eight-well Lab-Tek TM chamber were incubated with 100 nM Mitotracker Red CMXRos (Molecular Probes, Eugene, OR, USA) for 30 min at 371C in the culture medium. After incubation with CMXRos, the cells were washed with ice-cold PBS, and then fixed with 4% PFA in PBS for 30 min at 251C. Cells were permeabilized with 0.1% Triton X-100 for 5 min at 41C, and washed twice with ice-cold PBS, then incubated in blocking buffer (2% bovine serum albumin, 0.1% Tween-20, in PBS, pH 7.4) for 1 h at 251C. The primary antibody (anticytochrome c, clone 6H2.B4; 1 : 100; PharMingen, San Diego, CA, USA) that recognizes the native form of cytochrome c was then added to the cells at a concentration of 10 mg/ml for 4 h at 251C. After washing ice-cold PBS, biotin-conjugated anti-mouse IgG (1 : 1000; Vector Laboratories, Burlingame, CA, USA) was added for 2 h at 251C. After washing ice-cold PBS, the cells were then added streptavidin-FITC conjugates for 1 h at 251C (1 : 100; Venn Nova LLC, FL, USA). CMXRos and FITC fluorescence were observed under a fluorescence microscope.
2-Deoxy-D-[
3 H] glucose uptake ]-2-DG (1 mCi/well, 10 nM) was added to the six-well culture dishes in the beginning of culture and incubated for 2 h at 371C in 5%-CO 2 atmosphere. Uptake of [ 3 H]-2-DG was terminated by a rapid removal of the medium, followed by washes twice with ice-cold PBS (pH 7.4). The cells were lysed in 100 ml of 0.5 M NaOH, followed by neutralization with 0.5 M HCl. The radioactivity of collected cell lysates was determined by a liquid-scintillation counter. Cellular glucose incorporation was evaluated by the 
PKC kinase assay
Cultured cells were harvested using a solution containing 0.3% b-mercaptoethanol, 5 mM EDTA, 10 mM EGTA, 50 mg/ml PMSF, 10 mM benzamidine and 50 mM Tris-HCl (pH 7.5), homogenized on ice, and added to an equal volume of glycerol. PKC assay was performed using the Protein Kinase C enzyme assay system (Amersham Pharmacia Biotech, Piscataway, NJ, USA), according to the manufacturer's instructions with modifications. Briefly, the samples [S] were incubated with the substrate peptide, to be phosphorylated by PKC in 50 mM TrisHCl (pH 7.5), 30 mM dithiothreitol and [g-32 P]ATP in magnesium ATP buffer (1.2 mM ATP, 30 mM HEPES and 72 mM MgCl 2 , pH 7.4) for 15 min at 371C. Maximum PKC activation (Max) was obtained by further addition of 0.3 mg/ml La-phosphatidyl-L-serine, 24 mg/ml phorbol 12-myristate 13-acetate and 12 mM calcium acetate in 50 mM Tris-HCl (pH 7.5). Background activation [B] was obtained by omitting substrate peptide from [S] reaction mixture. After addition of stop solution, the reaction mixture was transferred onto peptide-binding paper. These papers were washed twice with 5% acetic acid and the incorporation of 32 P into peptide was determined by a liquid scintillation counter. 
Statistical analysis
For the statistical analysis of data, Student's t-test following multiple comparisons of the analysis of variance (ANOVA) was used. The criterion of significance was set at * or Po0.05. All results are expressed as the mean þ S.E.M.
